Literature DB >> 35989822

A Case of Cavitary Mycobacterium chimaera.

Bracha Robinson1, Moiuz Chaudhri1, Jeffrey A Miskoff2,3.   

Abstract

Mycobacterium chimaera is a nontuberculous mycobacterium typically associated with heater-cooler units used in cardiac bypass procedures and is usually of low virulence. Here we present a patient with advanced Mycobacterium chimaera infection without typical risk factors.
Copyright © 2022, Robinson et al.

Entities:  

Keywords:  cardiac bypass; heater-cooler units; lung disease; mycobacterium chimaera; nontuberculous mycobacterium

Year:  2022        PMID： 35989822      PMCID： PMC9385214          DOI： 10.7759/cureus.26984

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  11 in total

1.  Mycobacterium chimaera Spread from Heating and Cooling Units in Heart Surgery.

Authors:  Deborah Williamson; Benjamin Howden; Timothy Stinear
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

2.  Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States.

Authors:  Kiran M Perkins; Adrian Lawsin; Nabeeh A Hasan; Michael Strong; Alison L Halpin; Rachael R Rodger; Heather Moulton-Meissner; Matthew B Crist; Suzanne Schwartz; Julia Marders; Charles L Daley; Max Salfinger; Joseph F Perz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-14       Impact factor: 17.586

3.  Use of the INNO-LiPA-MYCOBACTERIA assay (version 2) for identification of Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex isolates.

Authors:  Léa Lebrun; François-Xavier Weill; Leila Lafendi; Florence Houriez; François Casanova; M Cristina Gutierrez; Didier Ingrand; Philippe Lagrange; Véronique Vincent; Jean Louis Herrmann
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.

Authors:  Geewon Lee; Kyung Soo Lee; Jung Won Moon; Won-Jung Koh; Byeong-Ho Jeong; Yeon Joo Jeong; Hak Jin Kim; Sookyoung Woo
Journal:  Ann Am Thorac Soc       Date:  2013-08

5.  Molecular identification of Mycobacterium chimaera as a cause of infection in a patient with chronic obstructive pulmonary disease.

Authors:  Nathan D Bills; Steven H Hinrichs; Tricia A Aden; Robert S Wickert; Peter C Iwen
Journal:  Diagn Microbiol Infect Dis       Date:  2009-03       Impact factor: 2.803

6.  Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov.

Authors:  Enrico Tortoli; Laura Rindi; Maria J Garcia; Patrizia Chiaradonna; Rosanna Dei; Carlo Garzelli; Reiner M Kroppenstedt; Nicoletta Lari; Romano Mattei; Alessandro Mariottini; Gianna Mazzarelli; Martha I Murcia; Anna Nanetti; Paola Piccoli; Claudio Scarparo
Journal:  Int J Syst Evol Microbiol       Date:  2004-07       Impact factor: 2.747

7.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

8.  Mycobacterium Chimaera: A Rare Presentation.

Authors:  Jeffrey A Miskoff; Moiuz Chaudhri
Journal:  Cureus       Date:  2018-06-06

9.  Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.

Authors:  Mina Gochi; Noboru Takayanagi; Tetsu Kanauchi; Takashi Ishiguro; Tsutomu Yanagisawa; Yutaka Sugita
Journal:  BMJ Open       Date:  2015-08-05       Impact factor: 2.692

10.  Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA.

Authors:  Nongnooch Poowanawittayakom; Anamika Dutta; Shannon Stock; Sunkaru Touray; Richard T Ellison; Stuart M Levitz
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.